<DOC>
	<DOCNO>NCT02545530</DOCNO>
	<brief_summary>The majority chronic hemodialysis patient need combination several antihypertensive drug adequate BP control . The primary objective study evaluate whether transdermal clonidine improve blood pressure control decrease oral antihypertensive agent type dosage secondary objective observe incidence adverse reaction transdermal clonidine chronic hemodialysis patient .</brief_summary>
	<brief_title>Transdermal Clonidine Chronic Hemodialysis Patients</brief_title>
	<detailed_description>It 's randomise crossover clinical trial . Subjects : chronic hemodialysis patient . All subject randomise 2 group . Subjects first group receive 4 week transdermal clonidine plus regular antihypertensive agent treatment first , 2weeks wash-out 4 week antihypertensive agent without transdermal clonidine . The group receive 4 week antihypertensive agent without transdermal clonidine first , 2weeks wash-out 4 week transdermal clonidine plus regular antihypertensive agent treatment . Ambulatory blood pressure , echocardiography , biochemistry detect .</detailed_description>
	<mesh_term>Clonidine</mesh_term>
	<criteria>1. sign informed consent ; 2. age : 18years 80 year old； 3. hemodialysis equal 3 month , less 3 time 12 hour hemodialysis per week； 4. cardiac function grade I grade II ( NYHA ) ； 5 . Using 1 1 oral antihypertensive drug , predialysis systolic blood pressure 140mmHg dialysis blood pressure 90mmHg , postdialysis systolic blood pressure 130mmHg diastolic blood pressure 80mmHg 1. acute infection within 1 month； 2. acute myocardial infarction/cardiac function grade IV/stroke within 3months； 3 . LVEF low 50 % echocardiography； 4 . Dry weight suitable BCM evaluation , plus minus 1kg； 5 . Interdialysis weight gain exceeds 5 % dry weight； 6 . Postdialysis systolic blood pressure low 120mmHg diastolic blood pressure low 70mmHg； 7 . Begin stop recombinant human erythropoietin treatment within 2 week inclusion 10 week inclusion ; 8 . Adjust recombinant human erythropoietin dosage 2times less half original dosage within 2 week inclusion 10 week inclusion； 9 . The treatment regimen amend within 10 week expect treatment amendment may affect blood pressure； 10 . Pregnancy lactation planning pregnancy 10 weeks； 11 . Expected withdraw hemodialysis treatment 10 weeks； 12 . Allergic clonidine accessories； 13 . Undergoing clinical study , research intervention impact blood pressure； 14 . Other clinical condition may affect result</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>renal dialysis</keyword>
	<keyword>hypertension</keyword>
	<keyword>clonidine</keyword>
</DOC>